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http://dx.doi.org/10.1016/j.ccr.2013.08.022SUMMARYWip1 phosphatase is emerging as an important regulator of tumorigenesis, but no unifying mechanistic
network has been proposed. We found that Wip1 plays a key role in the transcriptional regulation of hetero-
chromatin-associated DNA sequences. Wip1 was required for epigenetic remodeling of repetitive DNA ele-
ments through regulation of BRCA1 interaction with HP1, the recruitment of DNA methyltransferases, and
subsequent DNAmethylation. Attenuation of ATM, in turn, reversed heterochromatinmethylation. Thismech-
anismwas critical for the recruitment of the AID cytidine deaminase, andWip1 levels strongly correlated with
C-to-T substitutions and a total mutation load in primary breast cancers. We propose that Wip1 plays an
important role in the regulation of global heterochromatin silencing and thus is critical in maintaining genome
integrity.INTRODUCTION
Mammalian DNAmethylation occurs on cytosine residues within
CpG context and impacts several processes, including X chro-
mosome inactivation, imprinting, embryogenesis, gametogen-
esis, and tumorigenesis (Li, 2002; Smith and Meissner, 2013).
DNA methylation has been shown to silence transposons and
clustered DNA repeats that are present in heterochromatin re-
gions (Goll and Bestor, 2005). Despite the profound role of
DNA methylation in the regulation of developmental process
and diseases, the signaling pathways that may lead to global
change in methylation with resultant derepression of transposon
elements have not been fully elucidated. DNA methylation pat-
terns are commonly altered in human diseases, including cancer
(Gopalakrishnan et al., 2008). Neoplastic cells are typically char-
acterized by a global decrease in cytosine methylation (Toran˜o
et al., 2012), associated with an increase in the levels of RNA
transcribed from repeated DNA sequences that might contribute
to the genomic instability commonly observed in cancer.
The integrity of the genome is constantly challenged by
stresses, including DNA damage. To protect the stability of the
genome and to prevent disease, cells must activate severalSignificance
Understanding the factors contributing to tumor evolution is o
regulates global heterochromatin silencing. Thismechanism re
in-associated sequences in an ATM- and BRCA1-dependent
repressive complex containing HP1 and DNMT3B that is targe
ment of de novo DNAmethylation. In turn, regulation of DNAm
aminases andWip1 levels in primary human breast tumors corr
important factor that contributes to tumor heterogeneity, and t
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that involve the ataxia telangiectasia mutated (ATM) kinase,
have evolved to minimize the risk of inappropriate DNA rear-
rangements or translocations, ultimately protecting the cell
against genome instability (Lavin, 2008). Although the external
factors play an important role, activation of a DNA damage
response occurs naturally in a limited number of cells in vivo.
One of such examples is activation of a DNA damage response
during spermatogenesis (Fernandez-Capetillo et al., 2003).
Maturation of germ cells is characterized by time-specific acti-
vation of DNA damage markers, including phospho-gH2AX
(Kimmins and Sassone-Corsi, 2005). However, whether the
activation of the DNA damage response contributes to epige-
netic genome remodeling during spermatogenesis remains
largely unexplored.
Wip1 is a PP2C family serine/threonine phosphatase that has
been implicated in the regulation of several DNA damage- and
stress-induced signaling pathways. The gene encoding human
Wip1, PPM1D, is highly expressed in testis (Choi et al., 2002)
and is amplified in a variety of primary tumors (Bulavin et al.,
2002; Li et al., 2002). In several well-characterizedmouse cancer
models, Wip1 deletion leads to tumor suppression in variousf paramount significance. We found that Wip1 phosphatase
lied on a dynamic recruitment of DNMT3B to heterochromat-
manner. We provide evidence that BRCA1 may be part of a
ted to heterochromatin and is responsible for the establish-
ethylation byWip1modulated the recruitment of cytidine de-
elated with increased mutation rate. Thus, Wip1 could be an
hus its inhibition may decrease the rate of cancer evolution.
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Wip1 Controls Heterochromatin via DNA Methylationtissues, including the mammary gland, B cells, and the intestine
(Bulavin et al., 2004; Demidov et al., 2007; Shreeram et al.,
2006b). Loss of the Wip1 phosphatase results in activation of
the DNA damage response through modulation of the ATM/
Chk2- and ATR/Chk1-dependent signaling pathways. Impor-
tantly, activation of DNA damage pathways in Wip1-deficient
cells occurs in the absence of physically damaged DNA via up-
regulation of the activity of sensors of DNA damage, such as
ATM (Le Guezennec et al., 2012; Shreeram et al., 2006a,
2006b). Thus, genetic models that utilizeWip1 deletion or knock-
down strategies may faithfully replicate the conditions of
enhanced DNA damage response in human cell lines in vitro
and in mousemodels in vivo. Suchmodels may provide novel in-
sights into our understanding of certain aspects of epigenetic
regulation during development and tumorigenesis.
RESULTS
Wip1Deficiency Alters Heterochromatin and Attenuates
Spermatogenesis in Mice
Wip1-knockout males exhibited reduced fertility, suggesting a
role for this protein in the process of spermatogenesis (Choi
et al., 2002).Wip1messenger RNA (mRNA) expression progres-
sively increased throughout the prepubertal wave of mouse
spermatogenesis (Figure 1A) and in elutriated spermatocytes
and spermatids of adult mice (Figure 1B), suggesting a role dur-
ing germ cell differentiation. In agreement with previous observa-
tions (Choi et al., 2002), gross examination of Wip1-knockout
males revealed a marked reduction in testes size with a 40%
weight decrease when compared to wild-type (WT) littermates
(Figures S1A and S1B available online). On histological sections
Wip1-knockout testis displayed an abnormal architecture and
considerably narrower seminiferous tubules than those of wild-
type testis, accompanied by depletion of the most-differentiated
germ cell types (Figure 1C). No differences were found in testis
weight or sperm count between wild-type and Wip1-hetero-
zygous animals (data not shown). To find out the stages of
spermatogenesis affected by Wip1 deletion, we profiled the
expression of markers specific for each germ cell population.
In the absence of Wip1, we observed a marked reduction in
the expression of protamine, a protein specifically expressed in
spermatid cells (Figure S1C). Fluorescence-activated cell sorting
(FACS) analysis indicated that the decreased protamine expres-
sion inWip1 knockout testis correlated with reduced percentage
of spermatids (Figure 1D). Furthermore, the average epididymis
sperm count was reduced inWip1-knockout males (Figure S1D),
confirming that Wip1 deficiency affects spermatid production.
Analysis of Wip1-deficient and wild-type germ cells revealed
that DAPI-stained regions were enlarged and more diffuse in
the absence of Wip1, indicating a more condensed chromatin
structure. DAPI-dense areas often correspond to heterochro-
matin domains that were enriched in the heterochromatin protein
HP1 (Maison and Almouzni, 2004). These areas are also
commonly modified at the nucleosome level by DNAmethylation
at CpG dinucleotides (Bird and Macleod, 2004), histone hypoa-
cetylation (Jeppesen et al., 1992), and histone H3 trimethylation,
specifically at lysine 9 (H3K9me3) (Peters et al., 2001). Immuno-
fluorescent analysis revealed that the DAPI-dense centers prom-
inent in Wip1-deficient germ cells were enriched for bothCH3K9me3 (Figure 1E) and HP1g (Figure S1E) and concomitantly
depleted for histone H4 acetylation (Figure 1F). Heterochromatin
centers are mainly associated with repetitive DNA sequences,
such as satellite repeats and interspersed repetitive elements,
including transposons. These sequences are repressed in the
heterochromatin domains of somatic cells but are transcribed
during late stages of spermatogenesis in spermatids (Figure S1F)
and in cancer cells (Goodier and Kazazian, 2008). To ascertain
the functional relevance of the observed changes in heterochro-
matic structures in Wip1-deficient germ cells, we analyzed the
transcriptional status of known repetitive DNA sequences.
Quantitative RT-PCR showed a significant decrease in the level
of L1 LINEs (ORF2; Figure 1G), including active L1s (Figure S1G),
and IAP retroviruses together with Major and Minor Satellites,
whereas other interspersed repetitive sequences, including SI-
NE1B (Alu) elements, were largely unaffected (Figure 1G). To
assess the more general effect of Wip1 deficiency on transcrip-
tion in germ cells, we compared global gene expression profiles
betweenWip1-deficient and wild-type spermatids using spotted
microarray technology. In independent germ-cell purification
experiments, we detected differential gene expression and eval-
uated the functions of differentially expressed genes with Gene
Ontology (GO) annotation. The statistical significance of the
microarray data for the top ten up- and downregulated genes
were further confirmed by quantitative RT-PCR (Figure S1H),
which was overall in agreement with the relative expression
levels obtained from microarray analysis. We identified 1,217
unique genes that were associated with more than 1.4-fold
change in gene expression. Of the identified 625 were downre-
gulated in Wip1-deficient spermatids and significantly enriched
for GO categories involved in spermatids differentiation, repro-
duction functions, and chromatin organization (Figure S1I).
These results indicate that deletion of Wip1 increases the size
of heterochromatin centers, silences repetitive DNA sequences,
and globally alters gene expression.
Downregulation of Wip1 Is Accompanied by Epigenetic
Alterations and Increases Heterochromatin Silencing in
Cancer Cells
Interspersed and tandem repeated DNA sequences are dere-
pressed in several human tumors, contributing to the genomic
instability of cancer cells. Because Wip1 has been found to be
overexpressed in several cancers, promoting tumorigenesis
(Bulavin et al., 2004; Demidov et al., 2007; Shreeram et al.,
2006b), we next investigated the contribution ofWip1 to the tran-
scriptional status of repetitive sequences in cancer cells. We
generated a knockdown cancer cell line (HCT116) using RNA
interference with short hairpin RNA (shRNA) forWip1 (Figure 2A).
Quantitative RT-PCR showed that L1 LINEs (ORF2; Figure 2B),
active L1s (Figure S2A), and non mobile HERV-H were down
regulated in HCT116 cells upon depletion of Wip1. In addition,
upon Wip1 depletion, we also observed similar silencing in the
MCF7 cancer cell line (Figures 2C and S2B), indicating
that Wip1 is involved in controlling heterochromatin silencing in
cancer cells similar to the silence that was observed in germ
cells.
To gain mechanistic insight into the silencing of heterochro-
matin-related sequences in Wip1-depleted cells, we reasoned
that chromatin remodeling, particularly histone modificationsancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc. 529
Figure 1. Wip1 Deficiency Affects Spermatids Development and Impairs Heterochromatin Structure in Mice
(A and B) qRT-PCR showsWip1mRNA levels in wild-type testes obtained from 1- to 5-week-old mice (A) and purified germ cell populations from 10-week-old
mice (B). The following abbreviations are used: SSC, spermatogonial stem cells; DS, differentiated spermatogonia; SC, elutriated spermatocytes; SP, sper-
matids.
(C) Hematoxylin and eosin staining of wild-type mice (Wip1+/+) and knockout (Wip1/) testis.
(D) Analysis of germ cell populations based on DNA content evaluated by flow cytometry. The plot represents the percentage of cells with different content of
DNA: 1n (corresponds to spermatids), 2n (represents diploid cells), and 4n (corresponds to spermatocyte).
(E and F) Confocal images of testis sections from 10-week-old wild-type (Wip1+/+) andWip1 knockout (Wip1/) mice stained with antibodies against histone H3
trimethylation at lysine 9 (H3K9me3) (E) and acetylated histone H4 (H4Ac). (F) DNA was counterstained with DAPI (blue).
(G) qRT-PCR analysis shows the expression level of heterochromatin-associated sequences in Wip1 knockout (Wip1/) relative to wild-type (Wip1+/+) testis.
Statistical values were calculated using two-tailed t test. *p < 0.05; **p < 0.01; ***p < 0.001. Error bars indicate the mean ±SD.
See also Figure S1.
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Wip1 Controls Heterochromatin via DNA Methylationand potentially DNA methylation, may contribute to silencing, as
has been described for transcriptional control of DNA retroele-
ments (Hancks and Kazazian, 2012). We first analyzed modifica-
tions that correlate with gene activation, including histone
methylation (H3K4me3) and acetylation (H3K9Ac and total
H4Ac), or with repressed chromatin, including H3K9me3 and
H4K20me3. Enrichment of total histone H3was used to measure530 Cancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc.any large changes in nucleosome placement and density. Using
chromatin immunoprecipitation (ChIP) assays, we found that
Wip1 depletion resulted in marked enrichment of the repressive
histone marks H3K9me3 and H3K20me3, whereas H3K9 acety-
lation was significantly reduced on both L1 LINE and HERV-H
retroelements (Figure 2D). We next investigated whether Wip1
depletion affected the silencing of heterochromatin-related
Figure 2. Wip1 Depletion in Human Cancer Cells Alters the Expression and Epigenetic Status of Heterochromatin
(A)Wip1 RNA level in HCT116 parental (Wip1 WT) and HCT116Wip1-depleted (Wip1 SH) cells relative to ActinmRNA level (left panel). Wip1 protein level in Wip1
WT and Wip1 SH HCT116 cells (right panel). Actin was used as loading control.
(B and C) Analysis of mRNA levels forMajor andMinor Satellite, L1 LINE (ORF2), HERV-H, and SINE/Alu sequences in Wip1-depleted HCT116 (Wip1 SH) relative
to parental cells (Wip1 WT) (B) and Wip1-depleted MCF7 (MCF7 SH) relative to parental (MCF7 WT) cells. (C) 18S or ActinmRNA were used as internal controls.
(D) Enrichment of histone marks, including H3K4me3, H3k9Ac, H4Ac, H3K9me3, and H4K20me3, were analyzed on L1 LINE and HERV-H sequences in parental
and Wip1 SH HCT116 cells by ChIP assay. Total H3 levels were used as a loading control.
(E) Immunofluorescent analysis of global methylation using antibody against 5-methylcytosine (5meC).
(F) Changes in 5meC on L1 LINE and HERV-H sequences were evaluated in parental and Wip1 SH HCT116 cells by methylated DNA immunoprecipitations (left
panel) andmethyl-sensitive PCR (qMS-PCR) (right panel). A non-CpG site of L1 LINEDNAwas used as a negative control. Statistical values were calculated using
a two-tailed t test. **p < 0.01; ***p < 0.001. Error bars indicate the mean ± SD.
See also Figure S2.
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Wip1 Controls Heterochromatin via DNA Methylationsequences through modulation of DNA methylation. We first
evaluated the pattern of DNA methylation in Wip1-depleted
and parental HCT116 cells by immunostaining with 5-methyl-
cytidine antibody (5meC). Wip1 downregulation resulted in a
strong increase in 5meC nuclear staining (Figure 2E). Further-
more, pull-down experiments with 5meC antibody and qMS-
PCR (Figure 2F) revealed that methylation of L1 LINEs and
HERV-H sequences was significantly increased upon Wip1
depletion. We observed a similar pattern also in MCF7 cells (Fig-
ure S2C), indicating that the silencing of heterochromatin-related
sequences observed in different Wip1-depleted cancer cells is
accompanied by epigenetics changes.CSustained Activation of ATM Increases Global
Heterochromatin Silencing
We previously identified ATM as a direct target of Wip1 and
found that Wip1 deficiency resulted in ATM activation and a sig-
nificant delay in the onset of B lymphomas in an em-mycmodel of
cancer (Shreeram et al., 2006a, 2006b). In response to DNA
damage, ATM is recruited to the site of double-strand breaks
and is responsible for the phosphorylation and activation of
numerous downstream targets (Lavin, 2008). Because defi-
ciency of Wip1 does not induce DNA damage, phosphorylation
by ATM may be restricted only to a subset of downstream pro-
teins. We found that depletion of Wip1 resulted in increasedancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc. 531
Figure 3. Wip1 Depletion Activates ATM Signaling and Results in Recruitment of pBRCA1 to Retroelement Sequences
(A) SDS-PAGE of parental (WT) and Wip1 SH HCT116 cells (SH) treated with ATM inhibitor KU55933. Immunoblots were performed for different phosphorylated
and nonphosphorylated proteins as indicated.
(B) HCT116 Wip1 SH cells were treated with ATM inhibitor KU55933 (Wip1 SH ATMi), and the difference in mRNA expression of heterochromatin-associated
sequences was analyzed by qRT-PCR.
(C) BRCA1 deletion derepresses the heterochromatin-associated sequences in Wip1 SH HCT116. qRT-PCR shows the difference in mRNA expression of
heterochromatin-associated sequences relative to parental (Wip1 WT) HCT116 cells.
(D) Parental (Wip1 WT) and Wip1 SH HCT116 cells were cultured with DMSO or the ATM inhibitor KU55933. Cells were stained with antibody against pBRCA1
(red). DNA was counterstained with DAPI (blue).
(E) pBRCA1 recruitment to L1 LINE and HERV-H retroelements was analyzed by ChIP assay. Enrichment was analyzed in parental (Wip1 WT) and Wip1 SH
HCT116 cells with or without ATM inhibitor (ATMi). Statistical values were calculated using a two-tailed t test. **p < 0.01; ***p < 0.001. Error bars indicate the
mean ± SD.
See also Figure S3.
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Wip1 Controls Heterochromatin via DNA Methylationphosphorylation of ATM at Ser1981, as well as the phosphoryla-
tion of some, but not all, downstream effectors, including Chk2,
53BP1, and BRCA1 (Figure 3A). Importantly, this increase in532 Cancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc.phosphorylation was fully dependent on ATM activity and was
significantly reduced in the presence of the specific ATM inhibi-
tor KU55933 (Figure 3A).
Cancer Cell
Wip1 Controls Heterochromatin via DNA MethylationWe next analyzed whether deletion of Wip1 also results in acti-
vation of the ATM signaling pathway in germ cells. Because acti-
vated ATM has been shown to phosphorylate histone g-H2AX
(Burma et al., 2001), and because no reliable mouse phospho-
ATM antibody is available, we followed the kinetics of g-H2AX
phosphorylation through the stages of spermatogenesis. As pre-
viously reported (Haiman et al., 2011), immunofluorescence of
cross-sections of wild-type testes showed that g-H2AX localized
at the sex body in pachytene spermatocytes (Figure S3A) but
was nearly undetectable in spermatids (Figure S3A). In contrast,
Wip1-deficient males displayed sustained phosphorylation
of g-H2AX in the autosomal regions of pachytene spermatocytes
and in spermatids (Figure S3A). Cytological analysis of Wip1/
spermatocyte spreads confirmed that at pachytene stage phos-
pho-g-H2AX localized not only at the sex body, as in wild-type
cells, but also at autosomal chromosomes (Figure S3B). In addi-
tion, SYCP3 staining inWip1/ spermatocytes showed a defec-
tive organization of synaptonemal complex (Figure S3B). The
increased g-H2AX phosphorylation and the cytological defects
observed in Wip1-deficient germ cells were fully reversed
following deletion of a single allele of ATM (Figures S3B and
S3C), confirming thatWip1 deletion resulted in sustained activa-
tion of an ATM-dependent signaling pathway in germline cells
similar to that observed in cancer cells.
We next asked whether sustained activation of ATM signaling
in Wip1-depleted cells was mechanistically linked to the tran-
scriptional state of heterochromatin-related sequences. We
blocked the ATM pathway by treatment of Wip1-depleted
HCT116 cells with the ATM inhibitor KU55933 or small interfering
RNA (siRNA) and analyzed the transcript levels of heterochro-
matin-associated sequences. Quantitative RT-PCR showed
that ATM signaling was required for heterochromatin silencing
in Wip1-depleted HCT116 cells (Figures 3B and S3D) and in
Wip1-depleted MCF7 cells (Figure S3E). In addition, the mRNA
levels of L1 LINE and IAP sequences were fully reversed in
Wip1/ germ cells upon deletion of a single allele of ATM
(Figure S3F), suggesting that the effect ofWip1 deletion on het-
erochromatin silencing is, at least in part, dependent on the acti-
vation of ATM, both in germline and cancer cells.
To investigate the signaling pathway downstream of ATM that
may be responsible for heterochromatin silencing, we systemat-
ically depleted candidate proteins through a siRNA approach
and analyzed the effect of depletion on L1 LINE mRNA levels
(data not shown). Quantitative RT-PCR revealed that of the
numerous assayed candidates, depletion of BRCA1 resulted in
derepression of L1 LINE1 retrotransposons, HERV-H elements,
and Major and Minor Satellite sequences (Figure 3C). To under-
stand whether BRCA1 directly regulated the transcriptional sta-
tus of heterochromatin-associated sequences upon depletion of
Wip1, we first assayed phospho-BRCA1 localization (pBRCA1).
A significant increase in the intensity and spreading of pBRCA1
to DAPI-dense domains was found in Wip1-depleted HCT116
cells (Figure 3D). These changes were fully reversed following
treatment with KU55933 or after depleting ATM with siRNA (Fig-
ure 3G), suggesting that pBRCA1 enrichment on heterochromat-
in is dependent on ATM signaling. As BRCA1 is known to bind
chromatin, either directly or indirectly, we next evaluated
whether pBRCA1 directly occupies L1 LINE and HERV-H
elements. ChIP experiments showed that in Wip1-depletedCHCT116 cells, pBRCA1 was enriched on interspersed DNA se-
quences in an ATM-dependent manner (Figure 3E).
BRCA1 Modulates DNA Methylation at L1 LINE
Sequences and Mediates Heterochromatin Silencing
BRCA1 has recently been implicated in the control of hetero-
chromatin silencing through its E3 ligase activity and histone
H2A ubiquitination (Zhu et al., 2011). Surprisingly, we found no
difference in the enrichment of ubiquitinated histone H2A on L1
LINE or HERV-H sequences between parental and Wip1-
depleted HCT116 cells (Figure 4A). Since Wip1 deletion was
accompanied by altered epigenetic modifications both in cancer
and in germ cells, we next investigated whether the increase in
DNA methylation may account for heterochromatin silencing.
We found that 5-aza-cytidine (AZA) treatment, a well-established
inhibitor of DNA methylation, was sufficient to de-repress both
L1 LINE andHERV-H sequences inWip1-depleted HCT116 cells
(Figure 4B), suggesting the possible involvement of DNAmethyl-
ation in heterochromatin silencing. We next asked whether the
altered pattern of DNA methylation at L1 LINE sequences was
mechanistically linked to the ability of BRCA1 to silence tran-
scription. Depletion of BRCA1 reduced the global level of
5meC inWip1-depleted HCT116 cells, as confirmed by immuno-
fluorescence (Figure 4C). However, while depletion of BRCA1
had no effect on DNA methylation of L1 LINE and HERV-H
sequences in parental cells, the level of 5meC marking was
strongly reduced in Wip1-depleted HCT116 cells (Figure 4D).
In addition, BRCA1 depletion was able to reduce themethylation
status of repetitive sequences in Wip1-depleted MCF7 cells
(Figure S4A).
Only two mammalian enzymes, the DNA cytosine-5 methyl-
transferases, DNMT3A and DNMT3B, have been reported to
be responsible for de novo DNA methylation. In addition,
DNMT1 possesses DNA methylation-maintenance activity (Goll
and Bestor, 2005). Of these enzymes, DNMT3B was strongly
enriched on both L1 LINE and HERV-H sequences in Wip1-
depleted HCT116 cells in a BRCA1-dependent manner (Fig-
ure 4E). In contrast, while the enrichment of DNMT1 was not
significantly increased in Wip1-depleted cells; DNMT1 chro-
matin occupancy was still dependent on the presence of
BRCA1 (Figure S4B).
Because there is no clear evidence supporting the sequence-
specificity of the DNMTs, we reasoned that specific chromatin
modifiers may be involved in this process. It has been shown
that the heterochromatic protein HP1g is involved in the silencing
activities of the DNMTs (Lehnertz et al., 2003). In addition, a
recent report described a BRCA1-HP1g interaction (Choi et al.,
2012), further supporting a potential functional link between the
DNA methylation machinery and BRCA1-mediated silencing of
heterochromatin. We therefore checked whether BRCA1 coim-
munoprecipitates with HP1g. Pull-down experiments using
either pBRCA1 or HP1g antibodies showed that in Wip1-de-
pelted cells, pBRCA1 was efficiently associated with HP1g in
ATM-dependent manner (Figure 4F). Several BRCA1 domains
interacted with HP1g in pull-down assays (Figures S4C and
S4D) and since ATM activity was critically involved in BRCA1
binding to HP1g (Figure 4F), we next analyzed the ability of
BRCA1 phospho mutants to bind HP1g. Among multiple SQ/
TQ sites present on BRCA1, serines 1423 and 1524 are criticalancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc. 533
Figure 4. Depletion of BRCA1 Alters DNA Methylation on L1 LINE and HERV-H Retroelements
(A) ChIP assay for ubiquitinated histone H2A (H2Aub) enrichment on L1 LINE and HERV-H sequences in parental (Wip1 WT) and Wip1 SH HCT116 cells.
(B) HCT116 Wip1 SH cells were treated for 5 days with DNA methylation inhibitor 5-aza-cytidine (AZA). qRT-PCR shows L1 LINE and HERV-H mRNA levels in
Wip1 SH-treated cells relative to 18S and untreated cells.
(C) Parental (Wip1 WT) and Wip1 SH HCT116 cells were treated with BRCA1 or control siRNAs (CTRL). Cells were stained with 5meC antibody (red).
(D) Parental (Wip1WT) andWip1 SHHCT116 cells were treated with BRCA1 or control siRNAs. 5meC immunoprecipitation (left panel) and qMS-PCR (right panel)
show DNA methylation patterns.
(E) ChIP assay of DNMT3B enrichment on L1 LINE (left panel) and HERV-H (right panel) in parental (Wip1 WT) and Wip1 SH HCT116 cells treated with control or
BRCA1 siRNAs.
(F) Parental and Wip1 SH HCT116 cells were treated with the ATM inhibitor KU55933 and subjected to protein coimmunoprecipitation analysis with HP1g or
pBRCA1 antibodies and blotted for pBRCA1 or HP1g, respectively.
(G) Wip1-depleted HCT116 cells were transfected with full-length HA-tagged BRCA1 or S1423A/S1524A mutant (DPM). Cell extracts were subject to protein
immunoprecipitation with HA antibody and blotted for HP1g, DNMT3B, and HA.
(H) ChIP assay shows HP1g enrichment at L1 LINE and HERV-H sequences in HCT116 parental (Wip1 WT) or Wip1 SH cells with or without BRCA1 siRNA.
Statistical values were calculated using a two-tailed t test. **p < 0.01; ***p < 0.001. Error bars indicate the mean ± SD.
See also Figure S4.
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Figure 5. Deletion of a Single Allele of ATM Rescues a Spermatogenesis Defect in Wip1 Knockout Mice
(A and B) Analysis of overall size (A) and weight (B) of testes from 10-week-old wild-type, Wip1/ATM+/+, and Wip1/ATM+/ mice.
(C) Hematoxylin and eosin staining of whole testis sections from different genetic backgrounds as indicated.
(D) The percentage of germ cell populations in mice of different genetic backgrounds was analyzed as described in Figure 1D.
(E) Sections of paraffin-embedded testis from 10-week-old Wip1/ ATM+/+ and Wip1/ATM/+ mice were analyzed for histone H3 trimethylation at lysine 9
antibodies (H3K9me3) (shown in red). DNA was counterstained with DAPI (blue).
(F) Heatmap overview of the significantly rescued genes showing the probes being simultaneously differentially expressed in spermatids fromWip1/,Wip1/
ATM+/, and wild-type (Wip1+/+). The triplicates were generated from three independent germ cells purification experiments. Statistical values were calculated
using two-tailed t test. **p < 0.01. Error bars indicate the mean ± SD.
See also Figure S5.
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Wip1 Controls Heterochromatin via DNA Methylationfor proper responses to DNA damage (Cortez et al., 1999). An
in vitro pull-down assay showed that S1423A/S1524A BRCA1
mutant had reduced binding with both HP1g and DNMT3B (Fig-
ure 4G) further supporting a role for ATM phosphorylation of
BRCA1 in assembling of BRCA1-HP1g - DNMT3B complex.
Furthermore, HP1g was enriched on both L1 LINEs and HERV-
H sequences in a BRCA1-dependent manner (Figure 4H) sug-
gesting that BRCA1-dependent targeting of HP1g can be
involved in DNA methylation and heterochromatin silencing.CDeletion of a Single Allele of ATM Rescues
Spermatogenesis Defects inWip1-Deficient Mice
We next asked whether ATM deletion is sufficient to rescue the
spermatogenesis defects observed in Wip1-deficient mice.
Wip1+/ATM+/ mice were intercrossed to generate male litter-
mates of all required genotypes. Gross morphological examina-
tion showed that Wip1/ATM+/ testis were similar in size
and weight to those of wild-type mice (Figures 5A and 5B).
On histological sections, the seminiferous epithelium fromancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc. 535
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Wip1 Controls Heterochromatin via DNA MethylationWip1/ATM+/mice showed restoration of normal seminiferous
tubule architecture (Figure 5C). FACS analysis of various germ
cell types indicated that the number of spermatocytes and sper-
matids in Wip1/ATM+/ males was similar to that in wild-type
littermates (Figure 5D). Furthermore the epididymis sperm count
was comparable with wild-type male (Figure S5A) and
Wip1/ATM+/ male exhibited normal fertility when test-mated
with wild-type female (data not shown). While removal of a single
allele of ATM reversed the testis phenotype in Wip1-deficient
mice, analysis ofWip1/ATM/mice showed a complete early
arrest of spermatogenesis similar to ATM/males (Figure S5B).
ATM heterozygosity did not affect the transcriptional and
methylation status of heterochromatin-associated sequences
(Figures S5C and S5D). In contrast, removal of a single allele of
ATM was sufficient to decrease the size of the heterochromatin
centers in Wip1-deficient testis, as revealed by staining for the
heterochromatin marker H3K9me3 (Figure 5E). This experiment
confirmed that activation of ATM signaling in germ cells
accounted for the heterochromatin alterations observed in the
Wip1-deficient background. Importantly, microarray analysis
further confirmed that nearly 80% of genes that were differen-
tially expressed in Wip1-deficient germ cells were brought
back to the level observed in wild-type testes upon deletion of
a single allele ofATM (Figures 5F and S5E). Thus, our results indi-
cate that activation of ATM signaling accounts for the epigenetic
alterations at heterochromatin and the defects in spermatogen-
esis observed in Wip1-deficient mice.
ATM Signaling Is Indispensable for Modulation of DNA
Methylation at Heterochromatin
To understand the role of ATM in the regulation of the DNA
methylation we treated Wip1-depleted HCT116 cells with the
ATM inhibitor KU55933. Immunofluorescent analysis indicated
that the level of 5meC was significantly reduced in the presence
of the ATM inhibitor (Figure 6A). In line with this observation,
upon ATM inhibition or depletion with siRNA we found a strong
decrease in DNA methylation on L1 LINE and HERV-H
sequences in HCT116 (Figures 6B and S6A) andMCF7 cells (Fig-
ure S6B). Importantly, inhibition of ATM signaling was sufficient
to displace both DNMT3B and DNMT1 (Figures S6C and S6D)
from repetitive DNA sequences in HCT116 cells, suggesting
that activation of ATM signaling is required for the DNA methyl-
ation. A similar dependence of DNAmethylation on the presence
of Wip1 was observed in testis (Figure 6C). Deletion of a single
allele of ATM in Wip1-deficient males reduced the level of
5meC to that of wild-type littermates (Figures 6C and 6D).
We further asked whether ATM is required for establishing
global DNA methylation patterns during spermatogenesis.
Immunofluorescent analysis revealed a significant reduction in
the level of 5meC in ATM-deficient testis (Figure 6E) that strongly
correlated with a decrease in DNA methylation at repetitive DNA
sequences (Figure 6F). Furthermore, the altered pattern of DNA
methylation correlated with transcriptional derepression of L1
LINE and IAP elements (Figure 6G).
Overexpression ofWip1 in Primary Human Breast
Tumors Correlates with Somatic Hypermutations
To verify whether retroelements silencing observed in Wip1-
depleted cells was in fact due to lack of Wip1, we re-expressed536 Cancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc.Wip1 in HCT116 SH and MCF7 SH cells. We also used somatic
human embryonic kidney (HEK293) cells to understand the role
of Wip1 overexpression in regulation of retroelements. RT-PCR
analysis showed that in all cases overexpression of Wip1 signif-
icantly increased L1 LINE and HERV-HmRNA levels (Figure 7A).
These changes in retroelements levels were also accompanied
by a simultaneous decrease in DNA methylation and increase
in H3K4me3 (Figures 7B and S7A).
DNA methylation plays a central role in the generation of
mutations in human tumors. The cytidine deaminases, including
activation-induced cytidine deaminase (AID), are directly
involved in the generation of point mutations in human cancers
and targeted to specific sequences by histone modifications,
including H3K4 trimethylation (Chowdhury et al., 2008).To un-
derstand if Wip1 could be directly involved in the generation of
point mutations, we asked whether Wip1 regulates AID recruit-
ment through DNA methylation. ChIP experiments showed that
AID was enriched on L1 LINE and HERV-H sequences in both
parental MCF7 and HCT116 cells, whereas AID occupancy
was significantly reduced upon Wip1 depletion (Figure 7C). In
turn, Wip1 re-expression reversed AID recruitment to L1 LINE
and HERV-H sequences in both HCT116 and MCF7 Wip1 SH
cells (Figure 7C). Furthermore, the AID displacement from retro-
element sequences in Wip1-depleted cells was dependent on
DNA methylation because it was reversed after treatment with
5-aza-cytidine (Figure S7B).
Unmethylated cytosines have been shown to be substrates
of cytidine deaminases (Nabel et al., 2012). We found that
AID can be efficiently recruited to DNA in a Wip1-dependent
manner. This may result in conversion of cytosine to uracil,
creating a mismatch that is eventually repaired by the base-
excision repair (BER) mechanisms. As Wip1 is also a negative
regulator of BER (Lu et al., 2004), most of the incorporated ura-
cil may not be properly repaired prior to DNA replication when
Wip1 is overexpressed, thus creating C-to-T mutations by DNA
polymerases. As a result, tumors with high levels of Wip1 may
contain more somatic mutations. To verify this, we asked
whether Wip1 levels correlate with the number of C-to-T substi-
tutions and total mutation load in primary human breast tumors.
The Wip1 gene, PPM1D, is frequently amplified in primary
breast cancers, and next we analyzed microarray and somatic
mutation data sets (Koboldt et al., 2012). We found strong pos-
itive correlations between PPM1D copy number and the C-to-T
mutation load (Figure 7D) and overall base substitution muta-
tion load (Figure 7E). Importantly, tumors with high PPM1D
copy number had as much as a 50% increase in point muta-
tions. As Wip1 is also regulated at transcriptional level, we
next turned to the analysis of Wip1 mRNA expression relative
to mutation load in primary breast cancers. For comparison,
we included the analysis of APOBEC/AID family members,
among which APOBEC3B has been recently shown as a
considerable source of enzymatic mutation in breast cancer
(Burns et al., 2013). Our analysis identified a strong positive cor-
relation between Wip1, APOBEC3A, and APOBEC3B mRNA
expression levels and the C-to-T mutation load (Figure 7F)
and overall base substitution mutation load (Figure 7G). Taken
together, our data indicate that Wip1 could be an important
mutational source in breast cancer accounting for C-to-T muta-
tion biases and increased mutational loads.
Figure 6. ATM Signaling Is Indispensable for Modulation of DNA Methylation Patterns at Heterochromatin
(A) 5meC antibody staining in parental (Wip1 WT) and Wip1 SH HCT116 cells untreated or treated with ATM inhibitor KU55933.
(B) Methylated DNA 5meC immunoprecipitation (upper panel) and qMS-PCR (lower panel) shows DNA methylation patterns at L1 LINE and HERV-H elements in
parental (Wip1 WT) and Wip1 SH HCT116 cells treated with or without ATM inhibitor KU55933. A non-CpG site of L1 LINE DNA was used as a negative control.
(C) Cryo-sections of whole testis from wild-type (Wip1+/+), Wip1/ATM+/+, and Wip1/ATM+/ mice were stained with 5meC antibody and subjected to
confocal imaging.
(D) Analysis of 5meC enrichment (left panel) and qMS-PCR (right panel) on L1 LINEs and IAPs in germ cells from wild-type, Wip1/ATM+/+, and
Wip1/ATM+/mice.
(E) Confocal microscopy of cryo-sections using 5meC antibody shows loss of 5meC pattern in ATM-knockout testis.
(F) DNA methylation of L1 LINE and IAP sequences was analyzed after 5meC imuunoprecipitation in testis from wild-type and ATM knockout (ATM/) testis.
(G) mRNA levels of L1 LINE and IAP sequences in testis of ATM knockout (ATM/) mice relative to wild-type (ATM+/+). Statistical values were calculated using a
two-tailed t test. **p < 0.01; ***p < 0.001. Error bars indicate the mean ± SD.
See also Figure S6.
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AnalyzingWip1-deficient males, we and others originally noticed
that they have a profoundly attenuated fertility (Choi et al., 2002).
This observation prompted us to investigate spermatogenesis
and to identify a significant decrease in spermatid cells ac-
companied by a marked increase in the number and size of
heterochromatin centers and transcriptional silencing. The tran-
scriptional silencing observed in Wip1-deficient germ cells wasCsomewhat reminiscent of silencing of unsinapsed X and Y chro-
mosomes during pachytene stage of meiosis (Baarends et al.,
2005). At early stages, BRCA1 and g-H2AX are enriched on auto-
somal axial elements and relocalized to X-Y chromosomes at
pachytene; this coincides with meiotic sex chromosomes
silencing. Repressive epigenetic marks and modifiers, including
HP1, have also been implicated in meiotic sex chromosome
inactivation. Interestingly, in Wip1-deficient germ cells, despite
the onset of silencing and inactivation of sex chromosomes,ancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc. 537
Figure 7. Overexpression ofWip1 Derepresses Heterochromatin-Associated Sequences and Correlates with Somatic Mutations in Primary
Human Breast Tumors
(A) Wip1 was overexpressed in Wip1 SH MCF7, Wip1 SH HCT116, and HEK293 cell lines. qRT-PCR analysis of L1 LINE, HERV-H, and SINE (Alu) sequences
shows the difference relative to a control cell line.
(B) 5meC immuneprecipitations were analyzed for L1 LINE, andHERV-H sequences afterWip1 overexpression inWip1 SHMCF7,Wip1 SHHCT116, andHEK293
cells.
(C) ChIP assay of AID enrichment at L1 LINE andHERV-H sequences inWip1 SHHCT116 (left panel) andWip1 SHMCF7 (right panel) cells afterWip1 transfection.
Statistical values were calculated using two-tailed t test. *, **p < 0.01; *** p < 0.001. Error bars indicate the mean ± SD.
(D) A dot plot of the amount of C-to-T mutations per exome of each patient from the TCGA invasive breast cancer data set (mean levels are indicated). Patients
(778) were grouped into PPM1D nonamplified and amplified based on normal (0) and high (1+2) GISTIC scores. All p values are from a one-sided Mann–Whitney
U test.
(E) Same as in (D), but for all single base substitutions per exome.
(F) A dot plot of the amount of C-to-T mutations per exome of each patient from the TCGA invasive breast cancer data set (mean levels are indicated). Patients
(520) were grouped into the lower two-thirds and upper one-third based on expression levels of APOBEC3A, APOBEC3B, andWip1. All indicated p values are
from a one-sided Mann–Whitney U test.
(G) Same as in (F), but for all single base substitutions per exome.
(H) Amodel forWip1 regulation of heterochromatin via ATM/BRCA1-dependent DNAmethylation. Under normal conditions or uponWip1 depletion (upper panel),
ATM is activated, resulting in BRCA1 phosphorylation and subsequent recruitment of a repressive complex containing DNMT3b and HP1g to heterochromatin-
associated sequences. This is critical for establishment and the maintenance of 5meC patterns. Upon Wip1 overexpression (lower panel), Wip1 continuously
(legend continued on next page)
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Wip1 Controls Heterochromatin via DNA Methylationphospho-g-H2AXwas retained at autosomal regions. In turn, this
correlated with the silencing of heterochromatin-associated se-
quences and reduced expression of multiple genes. Similarly to
germ cells, Wip1 depletion in human cancer cells also induced
heterochromatin silencing.
A recent report showed that ubiquitination of histone H2A is
implicated in the repressionofa-satellite sequencesatpericentric
heterochromatin and thus may contribute to heterochromatic
silencing (Zhu et al., 2011). However, H2A-Ub was poorly
enriched on L1 LINE and HERV-H sequences, and we observed
no significant difference between parental and Wip1-depleted
HCT116 cells that could have accounted for the observed differ-
ences in the expression of these sequences. This finding sug-
gested that heterochromatin silencing inour experimentalmodels
was regulated throughadifferentmechanism. In somatic cells, re-
petitive sequences are extensively silenced by DNAmethylation;
alterations in this process are linked to genomic instability and
tumorigenesis (Hsiung et al., 2007; Iskow et al., 2010; Shukla
et al., 2013). In contrast to normal cells, inmanycasescancercells
display a loss of global DNA methylation (Baylin and Bestor,
2002). This general hypomethylation usually affects repetitive
DNA sequences, and recent work has demonstrated that
numerous epithelial cancers overexpress satellite repeats that
account for up to 50% of cellular transcripts (Ting et al., 2011).
In the present work, we found that Wip1 has an important role
in modulating DNA methylation at heterochromatin sequences,
including L1 LINE and HERV-H retrotroelements. In support for
a role of DNA methylation, treatment of cells with demethylating
agents and siRNA depletion of DNMTs (Figure S7D) were suffi-
cient to derepress heterochromatin-associated sequences in
Wip1-deficient cells. DNMT3B plays an important role in the
establishment of DNA methylation and the silencing of hetero-
chromatin. Because no sequence specificity for DNMTs has
been identified, the intermediate factors, such as HP1, may be
possibly involved in the BRCA1-dependent recruitment of
DNTM3B to heterochromatin. We observed that BRCA1 effi-
ciently binds HP1g upon activation of ATM, and both are
enriched on L1 LINEs. In turn, mutation of ATM phosphorylation
sites on BRCA1 significantly attenuated the binding of both
HP1g and DNMT3B. HP1g is normally recruited to heterochro-
matin in an H3K9me3-dependent manner (Lachner et al.,
2001), and we consistently detected an increase in H3K9me3
levels inWIP1-depleted cells; this correlated with the recruitment
of HP1g, BRCA1, and DNMT3B to both L1 LINEs and HERV-H
sequences. In turn, loss of BRCA1 decreased H3K9me3 levels,
HP1g occupancy, and DNA methylation. Interestingly, BRCA1
D223-763 mice (carrying a deletion of the region that also binds
HP1g) showed a significant reduction of survival rate compared
to BRCA1+/ (Shakya et al., 2011), further supporting that
BRCA1-HP1g interaction could be critically involved in tumor
suppressor functions of BRCA1.
Once established, DNA methylation is maintained through the
activity of DNMT1; the loss of DNA methylation observed in
DNMT1-deficent cells strongly supports its role in the mainte-silences ATM, preventing BRCA1 phosphorylation and complex formation with H
and is efficiently converted to uracil, creating a mismatch that is eventually repai
overexpression, DNA is demethylated, while BER is blocked, thus facilitating the
See also Figure S7.
Cnance of global DNA methylation of heterochromatin. We found
that DNMT1 recruitment on heterochromatin sequences is
dependent on the presence of BRCA1. In contrast to DNMT3B,
which was efficiently recruited to the repetitive sequences
upon depletion of Wip1, DNMT1 enrichment on heterochromatin
was not affected by this depletion. This observationmay suggest
that BRCA1 is responsible for basal recruitment of both DNMTs
to heterochromatin, whereas activation of ATM may further
enrich for DNMT3B occupancy to establish different DNA
methylation patterns.
The role of ATM signaling in the regulation of global DNA
methylation of heterochromatin extends the previously identified
functions of ATM at sites of double-strand breaks (Kruhlak et al.,
2006, 2007; Shanbhag et al., 2010) and in the regulation of L1
LINE retrotransposition (Coufal et al., 2011). Using Wip1- and
ATM-deficient mice and cells, we have demonstrated that ATM
is both necessary and sufficient to establish global DNA methyl-
ation. In our model (Figure 7H), activation of ATM signaling re-
sults in enhanced binding of pBRCA1 to the heterochromatin
protein HP1g, which correlates with H3-K9 methylation of het-
erochromatin-associated sequences. This complex may create
a docking site for subsequent recruitment of DNMT3B, which
places a 5meC mark on heterochromatin. Once this signature
is established, DNMT1 maintains the methylation pattern during
cell division and thus silences the heterochromatin transcription.
In turn, suppression of ATM activity results in heterochromatin
hypomethylation and re-expression of mobile DNA sequences.
As L1 LINE elements are causally linked to genome instability,
Wip1-dependent silencing of these regions could represent an
important protective mechanism from chromosomal rearrange-
ments and mutations.
DNA methylation plays a central role in the generation of mu-
tations in human tumors. The most common mutation in human
cells is C-to-T transitions, and this type of mutation is also found
very frequently in human tumors (Koboldt et al., 2012). Most of
these mutations occur at hydrolytically disfavored nonmethy-
lated cytosines throughout the genome, whereas a major frac-
tion of these transitions occur in the CpG context. Here, we
found that Wip1 regulated the recruitment of the AID cytidine
deaminase in a DNAmethylation-dependent manner. We further
found that Wip1 levels strongly correlated with C-to-T substitu-
tions and a total mutation load in primary breast cancers.
Unmethylated cytosine acts as a substrate for APOBEC/AID
deaminases that are commonly overexpressed in primary hu-
man cancers, including breast tumors (Burns et al., 2013; Nabel
et al., 2012). This results in deamination of cytosine to uracil,
removal of uracil by uracil DNA glycosylases (UDGs), and subse-
quent cytosine replacement by repair polymerases as part of the
BERmechanism. In the case of Wip1 overexpression, H3K4me3
is increased most likely providing a docking platform for cytidine
deaminases. Simultaneous increase in the total level of unmethy-
lated cytosines providesmore substrate for APOBEC/AID deam-
inases, while UDG activity is suppressed, thus blocking BER (Lu
et al., 2004). In this situation, uracil is not efficiently repaired priorP1g. In turn, unmethylated cytosine is a substrate of APOBEC/AID deaminases
red by the base-excision repair (BER) mechanisms. Under conditions of Wip1
generation of C-to-T mutations.
ancer Cell 24, 528–541, October 14, 2013 ª2013 Elsevier Inc. 539
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tion of A opposite U in the template by DNA polymerases (Fig-
ure 7E). Subsequent removal of U and insertion of T generates
the A:T transition, thus creating de novo mutation. In this sce-
nario, overexpression of Wip1 through increased mutation rate
conceptually could provide genetic fuel for cancer development,
metastasis, and potentially therapy resistance. In conclusion, we
suggest an important role for Wip1-dependent signaling in the
regulation of global DNA methylation, a mechanism that may
be critical for maintaining the integrity of the genome.
EXPERIMENTAL PROCEDURES
Animal Experimentation
Wip1 andATM knockout mice were previously described (Le Guezennec et al.,
2012). All work was done in compliance with the Institute of Molecular and Cell
Biology Animal Care and Use Committee-approved protocol to ensure animal
welfare.
qRT-PCR
Total RNA was purified using a Trizol kit (Invitrogen) and treated with DNase
(Ambion), and 0.5 mg was reverse transcribed using random primers and
SuperScript II (Invitrogen). Alternatively, for low starting material, an RNeasy
Micro Kit was used. Primers were used for SYBR green qPCR (Applied Bio-
systems), and their specificity was confirmed with dissociation curves. All
data are normalized to Gapdh, Actin, or 18S mRNA levels.
Chromatin Immunoprecipitation and Methylated DNA
Immunoprecipitation
Chromatin immune-precipitation was prepared in accordance with the Up-
state Biotechnology protocol, with some modifications. Methylated DNA
immunoprecipitation was carried out in accordance with the protocol laid
out by Guibert et al. (2012). Starting material was normalized between different
samples. Triplicate immunoprecipitations experiments were performed with
protein A/G-agarose beads (Millipore) and respective antibodies. Input and
immunoprecipitated samples were analyzed by SYBR Green qPCR with
respective primers. The relative enrichment of each marker was obtained
from qPCR as assayed by SYBR Green and calculated as the ratio between
the net intensity of each bound sample divided by the input.
Methyl-Sensitive PCR
DNA samples were extracted using DNA extraction kit from QIAGEN and sub-
jected to bisulfite conversion in accordance with Epitec Plus DNA Bisulfite Kit
(QIAGEN) guidelines. Quantitative data were generated as done previously
(Morandi et al., 2010) by PCR using methylation-specific primers and
expressed asmethylation index (%) that was calculated using the follow equa-
tion: methylation index = (M/(M + U)) 3 100, where M is the quantity of
methylated sequences after bisulfite conversion and U is the quantity of unme-
thylated sequences after bisulfite conversion.
Analysis of Point Mutations in Primary Breast Tumors
The mutation data of the invasive breast cancer data set were obtained from the
Cancer Genome Atlas (TCGA) (Koboldt et al., 2012). All expression and copy
number variation data were obtained from TCGA through the cgdsr (Cerami
et al., 2012) package in R. To define copy number variations, GISTIC scores
were used as reported by TCGA. A GISTIC score of zero defines the fraction of
patients with unchanged copy number, whereas GISTIC scores of one and two
were pooled in order to define the fraction of patients with significant
amplification.
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